These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25008847)

  • 21. An Unsual Cys-Glu-Lys Catalytic Triad is Responsible for the Catalytic Mechanism of the Nitrilase Superfamily: A QM/MM Study on Nit2.
    Silva Teixeira CS; Sousa SF; Cerqueira NMFSA
    Chemphyschem; 2021 Apr; 22(8):796-804. PubMed ID: 33463886
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth inhibitory effect of the human NIT2 gene and its allelic imbalance in cancers.
    Lin CH; Chung MY; Chen WB; Chien CH
    FEBS J; 2007 Jun; 274(11):2946-56. PubMed ID: 17488281
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional proteomic and structural insights into molecular recognition in the nitrilase family enzymes.
    Barglow KT; Saikatendu KS; Bracey MH; Huey R; Morris GM; Olson AJ; Stevens RC; Cravatt BF
    Biochemistry; 2008 Dec; 47(51):13514-23. PubMed ID: 19053248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conversion of aliphatic 2-acetoxynitriles by nitrile-hydrolysing bacteria.
    Heinemann U; Kiziak C; Zibek S; Layh N; Schmidt M; Griengl H; Stolz A
    Appl Microbiol Biotechnol; 2003 Dec; 63(3):274-81. PubMed ID: 12845494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurements of islet function and glucose metabolism with the dipeptidyl peptidase 4 inhibitor vildagliptin in patients with type 2 diabetes.
    Azuma K; Rádiková Z; Mancino J; Toledo FG; Thomas E; Kangani C; Dalla Man C; Cobelli C; Holst JJ; Deacon CF; He Y; Ligueros-Saylan M; Serra D; Foley JE; Kelley DE
    J Clin Endocrinol Metab; 2008 Feb; 93(2):459-64. PubMed ID: 18042650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biotransformation of heterocyclic dinitriles by Rhodococcus erythropolis and fungal nitrilases.
    Vejvoda V; Sveda O; Kaplan O; Prikrylová V; Elisáková V; Himl M; Kubác D; Pelantová H; Kuzma M; Kren V; Martínková L
    Biotechnol Lett; 2007 Jul; 29(7):1119-24. PubMed ID: 17479225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new nitrilase from Bradyrhizobium japonicum USDA 110. Gene cloning, biochemical characterization and substrate specificity.
    Zhu D; Mukherjee C; Yang Y; Rios BE; Gallagher DT; Smith NN; Biehl ER; Hua L
    J Biotechnol; 2008 Feb; 133(3):327-33. PubMed ID: 18061298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The nitrilase PtNIT1 catabolizes herbivore-induced nitriles in Populus trichocarpa.
    Günther J; Irmisch S; Lackus ND; Reichelt M; Gershenzon J; Köllner TG
    BMC Plant Biol; 2018 Oct; 18(1):251. PubMed ID: 30348089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans.
    Ahrén B; Schweizer A; Dejager S; Villhauer EB; Dunning BE; Foley JE
    Diabetes Obes Metab; 2011 Sep; 13(9):775-83. PubMed ID: 21507182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vildagliptin blocks vascular injury in thoracic aorta of diabetic rats by suppressing advanced glycation end product-receptor axis.
    Matsui T; Nishino Y; Takeuchi M; Yamagishi S
    Pharmacol Res; 2011 May; 63(5):383-8. PubMed ID: 21320599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fungal His-tagged nitrilase from Gibberella intermedia: gene cloning, heterologous expression and biochemical properties.
    Gong JS; Li H; Zhu XY; Lu ZM; Wu Y; Shi JS; Xu ZH
    PLoS One; 2012; 7(11):e50622. PubMed ID: 23226336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The islet enhancer vildagliptin: mechanisms of improved glucose metabolism.
    Ahrén B; Foley JE
    Int J Clin Pract Suppl; 2008 Mar; (159):8-14. PubMed ID: 18269436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural insights into enzymatic activity and substrate specificity determination by a single amino acid in nitrilase from Syechocystis sp. PCC6803.
    Zhang L; Yin B; Wang C; Jiang S; Wang H; Yuan YA; Wei D
    J Struct Biol; 2014 Nov; 188(2):93-101. PubMed ID: 25450592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
    He YL; Ligueros-Saylan M; Sunkara G; Sabo R; Zhao C; Wang Y; Campestrini J; Pommier F; Dole K; Marion A; Dole WP; Howard D
    J Clin Pharmacol; 2008 Jan; 48(1):85-95. PubMed ID: 17986525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion.
    El-Ouaghlidi A; Rehring E; Holst JJ; Schweizer A; Foley J; Holmes D; Nauck MA
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4165-71. PubMed ID: 17698900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the potential for steady-state pharmacokinetic interaction between vildagliptin and simvastatin in healthy subjects.
    Ayalasomayajula SP; Dole K; He YL; Ligueros-Saylan M; Wang Y; Campestrini J; Humbert H; Sunkara G
    Curr Med Res Opin; 2007 Dec; 23(12):2913-20. PubMed ID: 17931461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vildagliptin in clinical practice: a review of literature.
    Banerjee M; Younis N; Soran H
    Expert Opin Pharmacother; 2009 Nov; 10(16):2745-57. PubMed ID: 19874253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dipeptidyl peptidase 4 inhibition and vildagliptin therapy for type 2 diabetes.
    Del Prato S
    Int J Clin Pract Suppl; 2007 Aug; (154):38-48. PubMed ID: 17593276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of lipoyl vildagliptin, a novel dipeptidyl peptidase IV inhibitor after oral administration in rats.
    Wang X; Zhang D; Xu W; Liu H; Wang W
    Xenobiotica; 2010 Oct; 40(10):707-12. PubMed ID: 20735236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The DPP-4 inhibitor vildagliptin: robust glycaemic control in type 2 diabetes and beyond.
    Panina G
    Diabetes Obes Metab; 2007 Sep; 9 Suppl 1():32-9. PubMed ID: 17877545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.